The mechanism(s) of Ras deactivation in growth factor signalling: role and regulation of the tumor suppressor gene product neurofibromin
The mechanism(s) of Ras deactivation in growth factor signalling: role and regulation of the tumor suppressor gene product neurofibromin
批准号:
209439699
负责人:
Privatdozent Dr. Ignacio Rubio
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2011
资助国家:
德国
项目状态:
已结题
起止时间:
2010-12-31 至 2015-12-31
中文摘要
小g蛋白Ras是几乎所有有核细胞中细胞增殖的中心调节剂。Ras对生长因子的激活在本质上是短暂的,大量数据已经为Ras信号在细胞命运决策中的时间动态关键作用提供了证据。例如,在PC12神经内分泌细胞中,Ras/Erk信号的持续时间是诱导增殖(瞬时Ras/Erk信号)和分化(延长信号)的决定性因素。类似地,由致癌Ras引发的活性Ras的长时间和持续的放电被假设为驱动Ras转化细胞进入衰老的关键参数。因此,不仅要了解细胞如何协调Ras- gtp的形成,还要了解Ras信号如何终止以限制Ras信号持续时间,这在概念上具有重要意义。Ras激活的过程,即有丝分裂原刺激后Ras- gtp水平的激增,被详细理解。这是由于通过生长因子诱导的核苷酸交换因子(GEF)活性的增强,Ras上的核苷酸交换上调所致。相比之下,Ras失活的机制,即随后Ras- gtp水平的逆转,仍然不清楚。在RU860/4-1的持续研究中,我们揭示了GTP水解酶激活蛋白(GAP)神经纤维蛋白在Ras/MEK/Erk负反馈回路下的激活是Ras失活的机制。这是一个值得注意的发现,因为:首先,它从生物化学角度首次记录了生长因子信号传导中GAP的刺激,其次,它揭示了肿瘤抑制蛋白神经纤维蛋白的反馈信号换能器的作用,神经纤维蛋白是信号网络中未知功能的GAP物种。在这里申请的项目中,我们计划在Ras失活的背景下,详细研究和表征MEK/Erk与神经纤维蛋白刺激的生化过程。我们设想了这种联系的三种潜在机制:第一,Erk直接磷酸化神经纤维蛋白;第二Erk依赖的中间蛋白磷酸化,第三神经纤维蛋白不依赖的Ras微环境变化影响神经纤维蛋白对Ras的作用。实验程序,包括神经纤维蛋白相互作用的公正的蛋白质组学筛选和在几个新开始的合作中的一个背景下的修改,已经被设计为考虑所有这些情况。总之,RU860/4-1的研究结果揭示了一幅全新的有丝分裂瞬时Ras激活的图景,其特征是gef、Ras和神经纤维蛋白GAP的顺序激活。我们在这里申请资源继续这项工作一年多,以获得一个缺乏的信息,这将使我们能够缩小Erk和神经纤维蛋白之间的机制差距,并将帮助我们获得有丝分裂Ras激活/失活过程的全图。
英文摘要
The small G-protein Ras is a central regulator of cellular proliferation in essentially all nucleated cells. Ras activation in response to growth factors is transient in nature, and a large body of data has provided evidence for a critical role of the temporal dynamics of Ras signalling in cell-fate decision making. For example the duration of Ras/Erk signalling is decisive in inducing proliferation (transient Ras/Erk signal) versus differentiation (prolonged signal) in PC12 neuroendocrine cells. Similarly, prolonged and continuous firing from active Ras, as elicited by oncogenic Ras, is hypothesized to be a critical parameter driving Ras-transformed cells into senescence. It is hence of conceptual importance to understand not only how cells orchestrate Ras-GTP formation but also how the Ras signal is terminated to limit Ras signal duration.The process of Ras activation, i.e. the surge in Ras-GTP levels following mitogen stimulation, is understood in detail. It results from the up-regulation of nucleotide exchange on Ras via the growth factor induced enhancement of nucleotide exchange factor (GEF) activity. By contrast the mechanisms involved in Ras deactivation, i.e. the ensuing reversion of Ras-GTP levels, have remained obscure. During the ongoing work to RU860/4-1 we have disclosed activation of the GTP hydrolase activating protein (GAP) neurofibromin in the context of a negative Ras/MEK/Erk feedback loop as the mechanism underlying Ras deactivation. This is a remarkable finding because: 1st, it documents biochemically for the first time a stimulation of GAPs in growth factor signalling, and 2nd, it reveals a role as a feedback signal transducer for the tumour suppressor protein neurofibromin, a GAP species of unaccounted function in the signalling network.In the project applied for here we plan to investigate and characterize in detail the biochemical process linking MEK/Erk to neurofibromin stimulation in the context of Ras deactivation. We envisage three potential mechanisms for this connection: 1st direct phosphorylation of neurofibromin by Erk; 2nd Erk dependent phosphorylation of intermediary proteins, and 3rd neurofibromin-independent changes to the Ras microenvironment that affect neurofibromin action on Ras. The experimental program, including an unbiased proteomic screen of neurofibromin interactors and modifications in the context of one out of several newly started cooperations, has been designed to account for all these scenarios. In sum, our findings from RU860/4-1 reveal a fundamentally new picture of mitogenic transient Ras activation characterized by the sequential activation of GEFs, Ras, and the neurofibromin GAP. We apply here for resources to continue this work one more year in order to obtain one lacking piece of information that will allow us to close the mechanistic gap between Erk and neurofibromin and will help us obtain the full picture of the mitogenic Ras activation/deactivation process.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Role of SPRED1 and endocytosis in the regulation of the Ras/Erk pathwayand
-
批准号:399510179
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Privatdozent Dr. Ignacio Rubio
-
依托单位:
Isotype-specific analysis of Ras-subfamily member signalling using xanthine nucleotide selective mutants
-
批准号:5324397
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2001
-
负责人:Privatdozent Dr. Ignacio Rubio
-
依托单位:
国内基金
海外基金
登录
查看更多内容
金荞麦黄酮靶向抑制c-MET介导的PI3K/Akt和Ras/MAPK通路逆转NSCLC EGFR-TKI耐药的机制研究
-
批准号:2026JJ81256
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李弘德
-
依托单位:
槲皮素基于P53/Ras调控细胞凋亡增殖抗OSF癌变的机制研究
-
批准号:2026JJ82512
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王韧
-
依托单位:
lncRNA H19通过介导Ras/ULK1信号影响乳腺癌细胞线粒体稳态及糖酵解的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:施文标
-
依托单位:
组织驻留菌Eggerthella lenta 通过代
谢重编程Ras通路介导的细胞凋亡抑制结
直肠癌的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:陈一纬
-
依托单位:
新型污染物三(2-氯丙基)磷酸酯通过RAS/NLRP3信号通路致肾纤维化机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李升
-
依托单位:
赛沃替尼+西妥昔单抗+FOLFOX化疗对比西妥昔单抗+FOLFOX化疗一线治疗RAS/BRAF野生型转移性结直肠癌:一项前瞻性随机、对照、多中心、开放性研究
-
批准号:25SF1901600
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:许剑民
-
依托单位:
氨基酸突变Ras构象和作用机理的深入分
析导向肿瘤药物发现
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:曾娟
-
依托单位:
生育三烯酚调节RAS-ERK-MAPK通路促糖尿病溃疡愈合的机制研究
-
批准号:2025JJ80977
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:兰宏伟
-
依托单位:
全基因组CRISPR-Cas9筛选RAS/MAPK信号通路失活诱导非小细胞肺癌第三代EGFR-TKI耐药机制研究
-
批准号:JCZRLH202500317
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
牙周膜应力介导RAS信号通路调控破骨细胞增殖和分化促进牙周辅助加速正畸的机制研究
-
批准号:2025JJ70585
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:黄勉芳
-
依托单位: